Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Immunophenotypic-Defined Stage of Leukemia Differentiation Arrest Identifies Oncogenic and Metabolic Signatures in AML

Francois Vergez, DVM, PhD, Sarah Bertoli, MD PhD, Marina Bousquet, PhD, Marie-Laure Nicolau-Travers, Michael Peres, PharmD, Estelle Saland, Françoise Huguet, MD, Isabelle Luquet, MD, Veronique Mansat-de Mas, PharmD, PhD, Cecile Demur, MD, Eric Delabesse, MD PhD, Gwenn Danet-Desnoyers, PhD, Jean-Emmanuel Sarry, PhD, Christian Récher, MDPhD

Blood (2015) 126 (23): 90.

https://doi.org/10.1182/blood.V126.23.90.90

Published: 2015

Journal Articles

Dendrogenin_A : A Natural Liver X Receptor Modulator for the Treatment of Acute Myeloid Leukemia

Christian Recher, MDPhD, Marion David, PhD, Philippe de Medina, PhD, Cécile Bize, PhD, Nizar Serhan, PhD, Michael R Paillasse, PhD, Estelle Saland, Emmanuel Noguer, Julia Cherier, PhD, Cécile Demur, MDPhD, Clément Larrue, Fabienne de Toni, PhD, François Vergez, VMD-PhD, Jean-emmanuel Sarry, PhD, Sandrine Silvente-Poirot, PhD, Marc Poirot, PhD

Blood (2014) 124 (21): 3767.

https://doi.org/10.1182/blood.V124.21.3767.3767

Published: 2014

Journal Articles

Cytosine Arabinoside Chemotherapy Does Not Enrich For Leukemic Stem Cells In Xenotransplantation Model Of Human Acute Myeloid Leukemia

Fabienne de Toni, PhD, Robin L. Perry, MD, Estelle Saland, Mayumi Sugita, MD, Marion David, PhD, François Vergez, VMD, Eric Delabesse, MD, PhD, Véronique De Mas Mansat, PharmD PhD, Cécile Demur, MD, Jason Iacovoni, PhD, Stéphane Manenti, PhD, Gwenn Danet-Desnoyers, Christian Recher, MD PhD, Martin Carroll, MD, Jean-Emmanuel Sarry, PhD

Blood (2013) 122 (21): 1651.

https://doi.org/10.1182/blood.V122.21.1651.1651

Published: 2013

Journal Articles

Time from diagnosis to intensive chemotherapy initiation does not adversely impact the outcome of patients with acute myeloid leukemia

Sarah Bertoli, Emilie Bérard, Françoise Huguet, Anne Huynh, Suzanne Tavitian, François Vergez, Sophie Dobbelstein, Nicole Dastugue, Véronique Mansat-De Mas, Eric Delabesse, Eliane Duchayne, Cécile Demur, Audrey Sarry, Valérie Lauwers-Cances, Guy Laurent, Michel Attal, Christian Récher

Blood (2013) 121 (14): 2618–2626.

https://doi.org/10.1182/blood-2012-09-454553

Published: 2013

Includes: Supplemental data

Journal Articles

The cell cycle regulator CDC25A is a target for JAK2 V617F oncogene

Emilie-Fleur Gautier, Muriel Picard, Camille Laurent, Caroline Marty, Jean-Luc Villeval, Cécile Demur, François Delhommeau, Elizabeth Hexner, Stéphane Giraudier, Nicolas Bonnevialle, Bernard Ducommun, Christian Récher, Guy Laurent, Stéphane Manenti, Véronique Mansat-De Mas

Blood (2012) 119 (5): 1190–1199.

https://doi.org/10.1182/blood-2011-01-327742

Published: 2012

Includes: Supplemental data

Journal Articles

Identification of a transforming MYB-GATA1 fusion gene in acute basophilic leukemia: a new entity in male infants

Cathy Quelen, Eric Lippert, Stephanie Struski, Cécile Demur, Gwendoline Soler, Nais Prade, Eric Delabesse, Cyril Broccardo, Nicole Dastugue, François-Xavier Mahon, Pierre Brousset

Blood (2011) 117 (21): 5719–5722.

https://doi.org/10.1182/blood-2011-01-333013

Published: 2011

Includes: Supplemental data

Journal Articles

Conditional TPM3-ALK and NPM-ALK transgenic mice develop reversible ALK-positive early B-cell lymphoma/leukemia

Sylvie Giuriato, Marianne Foisseau, Emilie Dejean, Dean W. Felsher, Talal Al Saati, Cécile Demur, Ashraf Ragab, Anna Kruczynski, Claudine Schiff, Georges Delsol, Fabienne Meggetto

Blood (2010) 115 (20): 4061–4070.

https://doi.org/10.1182/blood-2008-06-163386

Published: 2010

Includes: Supplemental data

Journal Articles

Prognostic Impact of Mutations in the Nucleophosmin ( NPM1 ) and of the FMS-Related Tyrosine Kinase 3 ( FLT3 ) Genes in Elderly Patients with Acute Myeloid Leukemia (AML) Treated with Intensive Chemotherapy

Anne Etienne, Cecile Borel, Sarah Reutenauer, Sylviane Olschwang, Marie-Joelle Mozziconacci, Eric Delabesse, Cecile Demur, Thomas Prebet, Francoise Huguet, Aude Charbonnier, Christian Recher, Norbert Vey

Blood (2008) 112 (11): 2542.

https://doi.org/10.1182/blood.V112.11.2542.2542

Published: 2008

Journal Articles

The Level of AKT Phosphorylation on Threonine 308 but Not on Serine 473 Is Associated with High-Risk Cytogenetics and Predicts Poor Overall Survival in Acute Myeloid Leukemia.

Nathalie Gallay, PhD, Cédric Dos Santos, Lise Cuzin, MD, Marina Bousquet, Violaine Simonnet Gouy, Claire Chaussade, PhD, Michel Attal, MD, Bernard Payrastre, PhD, Cecile Demur, MD, Christian Recher, MD, PhD

Blood (2008) 112 (11): 1503.

https://doi.org/10.1182/blood.V112.11.1503.1503

Published: 2008

Journal Articles

A critical role for Lyn in acute myeloid leukemia

Cédric Dos Santos, Cécile Demur, Valérie Bardet, Nais Prade-Houdellier, Bernard Payrastre, Christian Récher

Blood (2008) 111 (4): 2269–2279.

https://doi.org/10.1182/blood-2007-04-082099

Published: 2008

Includes: Supplemental data

Journal Articles

Lyn Kinase Is Constitutively Activated, Controls the mTOR/p70S6K/4E-BP1 Pathway and Regulates Cell Proliferation in Acute Myeloid Leukemia.

Christian Recher, MD, Cedric Dos Santos, MD, Cecile Demur, MD, Valerie Bardet, MD,PhD, Nais Prade-Houdellier, Guy Laurent, MD,PhD, Bernard Payrastre, PhD

Blood (2006) 108 (11): 1946.

https://doi.org/10.1182/blood.V108.11.1946.1946

Published: 2006

Journal Articles

TNFα Stimulates NKG2D-Mediated Lytic Activity of Acute Myeloid Leukemic Cells.

Guy Laurent, Fabien Guilloton, Aurelie de Thonel, Christine Jean, Cecile Demur, Veronique De Mas, Anne Quillet-Mary

Blood (2005) 106 (11): 4411.

https://doi.org/10.1182/blood.V106.11.4411.4411

Published: 2005

Journal Articles

The IMPDH Inhibitor VX-944 Demonstrates In Vivo Efficacy in an Aggressive Leukemia Model.

Jugnu Jain, PhD, Jianguo Ma, PhD, Brinley Furey, BS, Christian Recher, MS, Cecile Demur, PhD, Srinivasu Poondru, PhD, Jianbo Zhang, PhD, Shaolan Li, MD, Brant Firestone, BS, Karen Olson, PhD, Maura Murphy, PhD, Jennifer Taylor, PhD, Greg Henkel, PhD, Edward Ball, MD, Yung-Mae Yao, PhD, Susan Almquist, MS, Russell Hoover, PhD

Blood (2004) 104 (11): 2530.

https://doi.org/10.1182/blood.V104.11.2530.2530

Published: 2004

Journal Articles

Activity of Rapamycin in Patients with Relapsed, Refractory or Poor-Risk Acute Myeloid Leukemia.

Christian Recher, MD, Odile Beyne-Rauzy, MD, Cecile Demur, MD, Françoise Huguet, MD, Guy Laurent, MD, Gaëtan Chicane, Cedric Dos Santos, Veronique Mansat-Demas, PhD, Bernard Payrastre, PhD

Blood (2004) 104 (11): 1791.

https://doi.org/10.1182/blood.V104.11.1791.1791

Published: 2004

Journal Articles

Tumor Necrosis Factor Alpha Inhibits Telomerase and Induces Senescence in Acute Myeloid Leukemia Cells.

Odile Beyne-Rauzy, Christian Recher, Nicole Dastugue, Nais Prade-Houdellier, Geraldine Pottier, Cecile Demur, Laure Sabatier, Guy Laurent, Veronique Mansat-DeMas

Blood (2004) 104 (11): 4456.

https://doi.org/10.1182/blood.V104.11.4456.4456

Published: 2004

NARROW

Immunophenotypic-Defined Stage of Leukemia Differentiation Arrest Identifies Oncogenic and Metabolic Signatures in AML

Dendrogenin_A : A Natural Liver X Receptor Modulator for the Treatment of Acute Myeloid Leukemia

Cytosine Arabinoside Chemotherapy Does Not Enrich For Leukemic Stem Cells In Xenotransplantation Model Of Human Acute Myeloid Leukemia

Time from diagnosis to intensive chemotherapy initiation does not adversely impact the outcome of patients with acute myeloid leukemia

The cell cycle regulator CDC25A is a target for JAK2 V617F oncogene

Identification of a transforming MYB-GATA1 fusion gene in acute basophilic leukemia: a new entity in male infants

Conditional TPM3-ALK and NPM-ALK transgenic mice develop reversible ALK-positive early B-cell lymphoma/leukemia

Prognostic Impact of Mutations in the Nucleophosmin ( NPM1 ) and of the FMS-Related Tyrosine Kinase 3 ( FLT3 ) Genes in Elderly Patients with Acute Myeloid Leukemia (AML) Treated with Intensive Chemotherapy

The Level of AKT Phosphorylation on Threonine 308 but Not on Serine 473 Is Associated with High-Risk Cytogenetics and Predicts Poor Overall Survival in Acute Myeloid Leukemia.

A critical role for Lyn in acute myeloid leukemia

Lyn Kinase Is Constitutively Activated, Controls the mTOR/p70S6K/4E-BP1 Pathway and Regulates Cell Proliferation in Acute Myeloid Leukemia.

TNFα Stimulates NKG2D-Mediated Lytic Activity of Acute Myeloid Leukemic Cells.

The IMPDH Inhibitor VX-944 Demonstrates In Vivo Efficacy in an Aggressive Leukemia Model.

Activity of Rapamycin in Patients with Relapsed, Refractory or Poor-Risk Acute Myeloid Leukemia.

Tumor Necrosis Factor Alpha Inhibits Telomerase and Induces Senescence in Acute Myeloid Leukemia Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only